News About: Pharm. Industry
Market share of domestic companies dips in March
Over the years, Korean firms have had to give up the home market to powerful global companies coming in with good medicine and better marketing strategies.
To make matters worse, the performance of Korean pharmaceu...
Corporate revenues up, profitability deteriorates
Korea’s pharmaceutical companies saw their revenues jump on growing demand last year.
But their ability to generate cash from a variety of operating activities fell on worsening profitability as a result of the to...
Hana Pharma spends 70% of revenue on promotion
Hana Pharmaceutical, one of 58 non-listed pharmaceutical firms, turned out to be the biggest spender on sales and administrative expenses last year, according to data released by Yakup Shinmoon.
The trade paper sai...
Vaccine makers fined 6 billion won for pricing rigging
Korea's antitrust watchdog said recently that it has slapped eight local vaccine makers with a combined 6.0 billion won in fines for rigging prices of influenza vaccine in state-run vaccine tender.
The FTC said tha...
Major firms forecast to suffer poor Q1 results
Major Korean pharmaceutical companies are likely to see their first-quarter earnings worsen sharply, buffeted by dramatic changes in the business environment such as regulations by the government, conflicts among drug...
Korean drugs overpriced, local paper claim
A leading daily newspaper recently criticized Korean drug makers for overpricing their products in the domestic market.
Chosun Ilbo called on the government and domestic companies to cut prices.
The paper report...
Samyang, Takeda to join forces in DDS platform technology
Samyang Corp. and Takeda Pharmaceutical have agreed to join hands to discover a novel DDS platform technology for RNAi therapeutics. Samyang has biopolymer technology that is considered to serve as a platform for nove...
Green Cross bids for WHO-led flu vaccine scheme
Green Cross Corp. said Thursday it has bid for a World Health Organization (WHO) scheme to provide its GC flu vaccine with an acquisition of WHO Prequalification on April 13.
Green Cross will submit a bid for the o...
16 multinational firms spend 6% of revenue on promotion
The country's 16 multinational drug companies on average spent six percent of their annual revenue on advertising and hospitality last year, according to Yakup Shinmoon (www.yakup.com).
According to data compiled b...
Drugmakers on alert over rebate crackdown
Marketing activities have recently shrunken as the government has launched its intensive crackdown to punish both distributors and medical personnel if the latter is found to have received a “rebate” or kickback while...
